| Dietary patterns and breast cancer risk: a systematic review A Dandamudi, J Tommie, L Nommsen-Rivers, S Couch Anticancer Research 38 (6), 3209-3222, 2018 | 157 | 2018 |
| Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis X Duan, R Perveen, A Dandamudi, R Adili, J Johnson, K Funk, ... Scientific Reports 11 (1), 13170, 2021 | 10 | 2021 |
| Rho GTPase signaling in platelet regulation and implication for antiplatelet therapies A Dandamudi, H Akbar, J Cancelas, Y Zheng International journal of molecular sciences 24 (3), 2519, 2023 | 5 | 2023 |
| Structure–Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents A Dandamudi, W Seibel, B Tourdot, JA Cancelas, H Akbar, Y Zheng International Journal of Molecular Sciences 24 (4), 4167, 2023 | 2 | 2023 |
| Autism-associated chromatin remodeler CHD8 regulates erythroblast cytokinesis and fine-tunes the balance of Rho GTPase signaling Z Tu, C Fan, AK Davis, M Hu, C Wang, A Dandamudi, KG Seu, TA Kalfa, ... Cell reports 40 (2), 2022 | 2 | 2022 |
| Structure-Activity Relationship Analysis of Analogs of Rhosin, a RhoA Inhibitor, Reveals a New Generation of Improved Antiplatelet Agents A Dandamudi, W Seibel, H Akbar, Y Zheng Blood 138, 3989, 2021 | | 2021 |